A phase I study of hydralazine to demethylate and reactivate the

Chronotropic Effect of Hydralazine and Its Mechanism in hydralazine

Key Messages: NAT2 slow acetylator status predicts increased hydralazine levels, which may lead to increased efficacy and adverse effects

hydralazine Hydralazine Printed copies are not controlled and may not be the current version in use Authorised by: Clinical Director Neonatal Page 1 of 2  Hydralazine is second line management for severe hypertension in pregnancy, and reserved for women in whom labetalol is contraindicated or not adequately Hydralazine is a direct vasodilator used orally to treat essential hypertension, among other diseases, and intravenously to rapidly reduce blood

จันทร์สดใส ใจสดชื่น C02DB02 Hydralazine D08044 Hydralazine Drug groups Cardiovascular agent DG03231 Antihypertensive DG00261 Hydralazine D08044 Hydralazine